ARTICLE | Company News
Purdue Pharma, Kissei Pharmaceutical deal
February 12, 2001 8:00 AM UTC
The companies mutually terminated a 1997 deal under which Purdue licensed North and South American rights to Kissei's Mitiglinide ( KAD-1229) oral short-acting insulin secretion stimulator for non-ins...